Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology
Pulmonary delivery is a promising alternative for the oral treatment of pulmonary aspergillosis. This study aimed to develop continuous and scalable itraconazole PEGylated nano-lipid carriers (ITZ-PEG-NLC) for inhalation delivery. The feasibility of preparing NLCs utilizing hot-melt extrusion (HME)...
Published in: | International Journal of Pharmaceutics: X |
---|---|
Main Authors: | , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doi.org/10.1016/j.ijpx.2021.100074 https://doaj.org/article/976cb0ee04e84701b828b8aaae3ada87 |
_version_ | 1821700039569833984 |
---|---|
author | Gauri Shadambikar Sushrut Marathe Nan Ji Mashan Almutairi Suresh Bandari Feng Zhang Mahavir Chougule Michael Repka |
author_facet | Gauri Shadambikar Sushrut Marathe Nan Ji Mashan Almutairi Suresh Bandari Feng Zhang Mahavir Chougule Michael Repka |
author_sort | Gauri Shadambikar |
collection | Directory of Open Access Journals: DOAJ Articles |
container_start_page | 100074 |
container_title | International Journal of Pharmaceutics: X |
container_volume | 3 |
description | Pulmonary delivery is a promising alternative for the oral treatment of pulmonary aspergillosis. This study aimed to develop continuous and scalable itraconazole PEGylated nano-lipid carriers (ITZ-PEG-NLC) for inhalation delivery. The feasibility of preparing NLCs utilizing hot-melt extrusion (HME) coupled with probe sonication was investigated. The process parameters for HME and sonication were varied to optimize the formulation. ITZ-PEG-NLC (particle size, 101.20 ± 1.69 nm; polydispersity index, 0.26 ± 0.01) was successfully formulated. The drug entrapment efficiency of ITZ-PEG-NLC was 97.28 ± 0.50%. Transmission electron microscopy was used to characterize the shape of the particles. The developed formulations were evaluated for their aerodynamic properties for pulmonary delivery. The lung deposition of ITZ-PEG-NLC was determined using an Anderson Cascade Impactor and Philips Respironics Sami the Seal Nebulizer Compressor. In vitro cytotoxicity studies were performed using A549 cells. A burst-release pattern was observed in ITZ-PEG-NLC with a drug release of 41.74 ± 1.49% in 60 min. The in vitro aerosolization of the ITZ-PEG-NLC formulation showed a mass median aerodynamic diameter of 3.51 ± 0.28 μm and a geometric standard deviation of 2.44 ± 0.49. These findings indicate that HME technology could be used for the production of continuous scalable ITZ-PEG-NLC. |
format | Article in Journal/Newspaper |
genre | sami |
genre_facet | sami |
id | ftdoajarticles:oai:doaj.org/article:976cb0ee04e84701b828b8aaae3ada87 |
institution | Open Polar |
language | English |
op_collection_id | ftdoajarticles |
op_doi | https://doi.org/10.1016/j.ijpx.2021.100074 |
op_relation | http://www.sciencedirect.com/science/article/pii/S2590156721000037 https://doaj.org/toc/2590-1567 2590-1567 doi:10.1016/j.ijpx.2021.100074 https://doaj.org/article/976cb0ee04e84701b828b8aaae3ada87 |
op_source | International Journal of Pharmaceutics: X, Vol 3, Iss , Pp 100074- (2021) |
publishDate | 2021 |
publisher | Elsevier |
record_format | openpolar |
spelling | ftdoajarticles:oai:doaj.org/article:976cb0ee04e84701b828b8aaae3ada87 2025-01-17T00:37:27+00:00 Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology Gauri Shadambikar Sushrut Marathe Nan Ji Mashan Almutairi Suresh Bandari Feng Zhang Mahavir Chougule Michael Repka 2021-12-01T00:00:00Z https://doi.org/10.1016/j.ijpx.2021.100074 https://doaj.org/article/976cb0ee04e84701b828b8aaae3ada87 EN eng Elsevier http://www.sciencedirect.com/science/article/pii/S2590156721000037 https://doaj.org/toc/2590-1567 2590-1567 doi:10.1016/j.ijpx.2021.100074 https://doaj.org/article/976cb0ee04e84701b828b8aaae3ada87 International Journal of Pharmaceutics: X, Vol 3, Iss , Pp 100074- (2021) Itraconazole PEGylation Hot-melt extrusion Pulmonary drug delivery Inhalation Nanostructured lipid carriers Pharmacy and materia medica RS1-441 article 2021 ftdoajarticles https://doi.org/10.1016/j.ijpx.2021.100074 2022-12-31T07:46:11Z Pulmonary delivery is a promising alternative for the oral treatment of pulmonary aspergillosis. This study aimed to develop continuous and scalable itraconazole PEGylated nano-lipid carriers (ITZ-PEG-NLC) for inhalation delivery. The feasibility of preparing NLCs utilizing hot-melt extrusion (HME) coupled with probe sonication was investigated. The process parameters for HME and sonication were varied to optimize the formulation. ITZ-PEG-NLC (particle size, 101.20 ± 1.69 nm; polydispersity index, 0.26 ± 0.01) was successfully formulated. The drug entrapment efficiency of ITZ-PEG-NLC was 97.28 ± 0.50%. Transmission electron microscopy was used to characterize the shape of the particles. The developed formulations were evaluated for their aerodynamic properties for pulmonary delivery. The lung deposition of ITZ-PEG-NLC was determined using an Anderson Cascade Impactor and Philips Respironics Sami the Seal Nebulizer Compressor. In vitro cytotoxicity studies were performed using A549 cells. A burst-release pattern was observed in ITZ-PEG-NLC with a drug release of 41.74 ± 1.49% in 60 min. The in vitro aerosolization of the ITZ-PEG-NLC formulation showed a mass median aerodynamic diameter of 3.51 ± 0.28 μm and a geometric standard deviation of 2.44 ± 0.49. These findings indicate that HME technology could be used for the production of continuous scalable ITZ-PEG-NLC. Article in Journal/Newspaper sami Directory of Open Access Journals: DOAJ Articles International Journal of Pharmaceutics: X 3 100074 |
spellingShingle | Itraconazole PEGylation Hot-melt extrusion Pulmonary drug delivery Inhalation Nanostructured lipid carriers Pharmacy and materia medica RS1-441 Gauri Shadambikar Sushrut Marathe Nan Ji Mashan Almutairi Suresh Bandari Feng Zhang Mahavir Chougule Michael Repka Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology |
title | Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology |
title_full | Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology |
title_fullStr | Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology |
title_full_unstemmed | Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology |
title_short | Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology |
title_sort | formulation development of itraconazole pegylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology |
topic | Itraconazole PEGylation Hot-melt extrusion Pulmonary drug delivery Inhalation Nanostructured lipid carriers Pharmacy and materia medica RS1-441 |
topic_facet | Itraconazole PEGylation Hot-melt extrusion Pulmonary drug delivery Inhalation Nanostructured lipid carriers Pharmacy and materia medica RS1-441 |
url | https://doi.org/10.1016/j.ijpx.2021.100074 https://doaj.org/article/976cb0ee04e84701b828b8aaae3ada87 |